tradingkey.logo
tradingkey.logo

Inogen Inc

INGN
6.750USD
+0.040+0.60%
終値 12/22, 16:00ET15分遅れの株価
183.25M時価総額
損失額直近12ヶ月PER

Inogen Inc

6.750
+0.040+0.60%

詳細情報 Inogen Inc 企業名

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Incの企業情報

企業コードINGN
会社名Inogen Inc
上場日Feb 14, 2014
最高経営責任者「CEO」Smith (Kevin R. M)
従業員数766
証券種類Ordinary Share
決算期末Feb 14
本社所在地859 Ward Drive
都市GOLETA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号93111
電話番号18055620500
ウェブサイトhttps://www.inogen.com/
企業コードINGN
上場日Feb 14, 2014
最高経営責任者「CEO」Smith (Kevin R. M)

Inogen Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
U.S. revenue
56.35M
61.07%
Non-U.S. revenue
35.92M
38.93%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
他の
72.04%
株主統計
株主統計
比率
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
他の
72.04%
種類
株主統計
比率
Investment Advisor
25.98%
Investment Advisor/Hedge Fund
25.85%
Hedge Fund
18.26%
Corporation
9.67%
Individual Investor
2.48%
Research Firm
1.98%
Family Office
0.89%
Pension Fund
0.27%
Bank and Trust
0.20%
他の
14.42%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.71%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
5.61%
-63.70K
-4.03%
Jun 30, 2025
The Vanguard Group, Inc.
1.65M
6.12%
+113.18K
+7.35%
Jun 30, 2025
Acadian Asset Management LLC
1.02M
3.76%
-11.08K
-1.08%
Jun 30, 2025
Camber Capital Management LP
975.00K
3.61%
--
--
Jun 30, 2025
Armistice Capital LLC
664.00K
2.46%
+664.00K
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
881.10K
3.26%
+6.57K
+0.75%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
832.19K
3.08%
+75.07K
+9.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
615.28K
2.28%
+44.86K
+7.86%
Jun 30, 2025
Dafna Capital Management, LLC
605.63K
2.24%
+147.56K
+32.21%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
詳細を見る
Cultivar ETF
比率0.59%
Invesco NASDAQ Future Gen 200 ETF
比率0.55%
Federated Hermes MDT Small Cap Core ETF
比率0.25%
JPMorgan Fundamental Data Science Small Core ETF
比率0.11%
iShares Micro-Cap ETF
比率0.04%
Avantis US Small Cap Equity ETF
比率0.02%
Proshares Ultra Russell 2000
比率0.01%
ProShares Hedge Replication ETF
比率0.01%
ProShares UltraPro Russell2000
比率0.01%
Global X Russell 2000 ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Inogen Incの上位5名の株主は誰ですか?

Inogen Incの上位5名の株主は以下のとおりです。
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOPは2.63M株を保有しており、これは全体の9.71%に相当します。
BlackRock Institutional Trust Company, N.A.は1.52M株を保有しており、これは全体の5.61%に相当します。
The Vanguard Group, Inc.は1.65M株を保有しており、これは全体の6.12%に相当します。
Acadian Asset Management LLCは1.02M株を保有しており、これは全体の3.76%に相当します。
Camber Capital Management LPは975.00K株を保有しており、これは全体の3.61%に相当します。

Inogen Incの株主タイプ上位3種は何ですか?

Inogen Incの株主タイプ上位3種は、
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

Inogen Inc(INGN)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Inogen Incの株式を保有している機関は308社あり、保有株式の総市場価値は約19.98Mで、全体の73.65%を占めています。2025Q2と比較して、機関の持ち株は-11.03%増加しています。

Inogen Incの最大の収益源は何ですか?

FY2025Q2において、--部門がInogen Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI